Find expert answers to your health questions

Camille McGann

Bio

Dr. Camille McGann practices in the Washington DC metropolitan area.  She completed her Residency Training in Radiation Oncology at Northwestern Memorial Hospital in Chicago, IL.  She is the President and CEO of Legacy Educators and Consultants, LLC, an educational company developed to bridge the “patient-physician” gap.  At the heart of everything she does is empowerment through education and advocacy, starting with the people of the community.
 
During her years in the teaching arena she developed a mode of communicating difficult topics in an effortless and simplistic manner to people of different social status. LegacyEducators.com was developed as a result of her desire to reach a greater population in the specialty of Oncology. It is a “visual learning” tool to teach the basics of Cancer.  She skillfully integrated animations/videos to appeal to the visual learners and provided questions to ask Doctors that can be downloaded and taken on appointments. There are also links to well established websites to read additional information on diagnosis, treatment and side effects.
 
Her passion is to encourage knowledge and understanding of the difficult topic of Cancer through Seminars, health fairs and local Church programs.

Please visit her site www.LegacyEducators.com for more information.

Specialties:

Affiliation:

  • Legacy Educators and Consultants, LLC

Location:

Activity

  • Sharecare News
    Sharecare News posted a story about Oncology:
    Pets Battling Cancer Can Join Clinical Trials Too

    THURSDAY, June 13 (HealthDay News) -- If you hear that a friend's beloved family member has joined a clinical trial for cancer treatment, don't assume the patient is human.

    Cancer is the leading cause of death in older dogs and cats, and clinical trials offer ho...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:
    Xgeva Approved for Rare, Non-Malignant Tumor

    THURSDAY, June 13 (HealthDay News) -- Xgeva (denosumab) has been approved by the U.S. Food and Drug Administration to treat giant cell tumor of the bone (GCTB), a rare tumor that's most often non-cancerous.

    The tumor usually affects adults between ages 20 and 40, although it may also deve...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:
    Xgeva Approved for Rare, Non-Malignant Tumor

    THURSDAY, June 13 (HealthDay News) -- Xgeva (denosumab) has been approved by the U.S. Food and Drug Administration to treat giant cell tumor of the bone (GCTB), a rare tumor that's most often non-cancerous.

    The tumor usually affects adults between ages 20 and 40, although it may also deve...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:
    Which Women Might Benefit From Drugs to Prevent Breast Cancer?

    THURSDAY, June 13 (HealthDay News) -- Newly identified genetic variations may help predict which women will respond to breast cancer prevention therapy, a new study suggests.

    By determining who would and would not receive possible benefit from two preventive dru...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:
    Scientists ID Gene Linked to Aggressive Liver Cancer

    WEDNESDAY, June 12 (HealthDay News) -- Researchers have found a gene they say can help identify patients facing aggressive liver cancer, and may prove key to their future treatment.

    This is good news in a field "that has not had big advances before this and has not been the beneficiary of...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:
    Experts Dispel Common Melanoma Myths

    FRIDAY, June 7 (HealthDay News) -- As you head to the beach or pool, here are some sun-sense tips to keep in mind: Skin that tans is not invulnerable to cancer, and one application of sunscreen daily is not enough protection against the sun's harmful ultra-violet rays, according to skin cancer ex...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:
    Tumor in Bone Shows Neanderthals Got Cancer Too

    THURSDAY, June 6 (HealthDay News) -- Cancer is often lamented as a modern-day scourge, but researchers have discovered a type of bone cancer in a 120,000-year-old Neanderthal rib.

    Before this discovery was made in Krapina, Croatia, the earliest evidence of this type of bone tumor, known a...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:
    Almost Half of Cancer Doctors Report Symptoms of Burnout: Survey

    WEDNESDAY, June 5 (HealthDay News) -- Most cancer doctors are satisfied with their career, but nearly half say they have experienced at least one symptom of work-related burnout, a new study finds.

    Researchers surveyed 3,000 U.S. oncologists between October 2012 and January 2013, and foun...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:
    Cancer Patients Often Shy Away From Talking About Costs

    TUESDAY, June 4 (HealthDay News) -- Although most cancer patients want to talk about the price tag of cancer treatment, they don't actually do it, a new study has found. Many patients are afraid the discussion could compromise the quality of their care.

    Those who do bring up their financ...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:
    Fine-Tuning Breast Cancer Treatments: What Works Better?

    MONDAY, June 3 (HealthDay News) -- Two common schedules used for the chemotherapy paclitaxel (Taxol) are equally effective at controlling breast cancer, but fewer side effects are found with the weekly regimen rather than every two weeks, according to a new study.

    The estimated five-year ...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:
    Michael Douglas Blames His Throat Cancer on Oral Sex

    MONDAY, June 3 (HealthDay News) -- Hollywood star Michael Douglas says oral sex caused his recent bout with throat cancer.

    "Without wanting to get too specific, this particular cancer is caused by HPV, which actually comes about from cunnilingus," Douglas, 68, told the British newspaper <...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:
    U.S. Cancer Patients Suffering From Drug Shortages

    MONDAY, June 3 (HealthDay News) -- Four out of five U.S. cancer doctors encountered shortages of essential drugs between March and September of 2012, which affected the quality of care they provided and increased treatment costs, new research shows.

    The survey of 250 cancer doctors across...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:
    New Drug May Help Fight Certain Advanced Lung Cancers

    MONDAY, June 3 (HealthDay News) -- For patients struggling with a common and deadly form of lung cancer, adding the drug ganetespib to a standard chemotherapy drug may boost survival, new research suggests.

    The finding centers on a class of medications known as heat shock protein 90 (Hsp9...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:
    Most Docs OK With Medical Marijuana: Survey

    WEDNESDAY, May 29 (HealthDay News) -- Three-quarters of doctors who responded to a survey about medical marijuana said they would approve the use of the drug to help ease pain in an older woman with advanced breast cancer.

    In a February issue of the New England Journal of Medicine,...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:
    CT Scans Reduce Lung Cancer Deaths, Study Confirms

    WEDNESDAY, May 22 (HealthDay News) -- Physicians weighing the benefits and risks of CT scans for detecting lung cancer now have more information to help with the decision. A new analysis of a 2010 U.S. study finds that low-dose CT scans pick up significantly more lung tumors than chest X-rays do....Full Article